🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase 2/3 study to determine the efficacy, safety and immunogenicity of t...
Status
Completed
Location
University Hospital Southampton NHS Foundation Trust
Start Date
2020-05-28
Trial ID
NCT04400838
Treatments Being Tested
Investigating the role of 13cis retinoic acid in the treatment of COVID-19 ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-07
Trial ID
NCT04730895
Treatments Being Tested
The aim of the study is to assess the safety, and immunogenicity of AZD2816...
Status
Completed
Location
Research Site
Start Date
2021-06-27
Trial ID
NCT04973449
A phase I/II single-blinded, randomised, multi-centre study to determine ef...
Status
Completed
Location
University Hospital Southampton NHS Foundation Trust
Start Date
2020-04-23
Trial ID
NCT04324606
To determine whether a heterologous vaccination regimen in individuals with...
Status
Unknown
Location
Hospital Ramos Mejía
Start Date
2021-07-26
Trial ID
NCT04983537
Treatments Being Tested
The 8-week, Prospective, Randomized controlled of IntraDermal administratio...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-08-31
Trial ID
NCT05029245
Treatments Being Tested
Chronic kidney disease (CKD) including patients on dialysis and kidney tran...
Status
Completed
Location
Faculty of Medicine,Vajira Hospital
Start Date
2021-06-01
Trial ID
NCT05057936
Treatments Being Tested
The aim of this study is to assess the immunogenicity and safety of AZD1222...
Status
Terminated
Location
Research Site
Start Date
2022-01-31
Trial ID
NCT05057897
Treatments Being Tested
This study aimed to provide vast clinical information to facilitate breast ...
Status
Completed
Location
ChiMei Medical Center
Start Date
2023-01-01
Trial ID
NCT06429020
This is a phase III, randomized, observer-blind, active-controlled, paralle...
Status
Completed
Location
Trial site
Start Date
2022-10-01
Trial ID
NCT05572879
Treatments Being Tested